Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2015

View Archived Issues

Novel sedative compares favorably with propofol in dogs

Janssen's gamma-secretase modulator effective in AD models

AAV-mediated gene delivery shows promising results in AD models

New results presented for lapatinib in the treatment of recurrent ependymoma

Daiichi Sankyo receives approval in Japan for methylene blue

China organizations disclose analgesic frog skin oligopeptide

Merck & Co. reports new HIV integrase inhibitors

Kaken discloses novel EP4 receptor antagonists

Astellas presents compounds for breast cancer

Helix BioMedix patents human C-X-C chemokine-derived peptides

Innovate Biopharmaceuticals to acquire RG-1068 assets

Vectura to apply its inhaled drug delivery technology to Janssen asthma and COPD candidates

Minerva Neurosciences' neuregulin-1 analogue shows activity in primate model of Parkinson's disease

FDA approves Gadavist as contrast agent for pediatric patients under age 2

Phase III trial of perampanel in refractory partial-onset seizures meets primary endpoint

Manufacturing and distribution approval for selective SGLT2 inhibitor for diabetes

CytRx reports interim results from phase II trial of aldoxorubicin in GBM

BrainStorm Cell Therapeutics reports final results from phase IIa ALS study of NurOwn

Alnylam files application for phase I trial of ALN-AS1

Cenicriviroc receives FDA Fast Track designation

FDA awards fast track designation to IMMU-132 for triple-negative breast cancer

Sirnaomics files Chinese IND application for STP-705 for hypertrophic scars

Taiho files Japanese NDA for Yondelis in soft tissue sarcoma

European orphan drug designation for Kite Pharma's KTE-C19 for DLBCL

FDA grants orphan drug status to selinexor for multiple myeloma

Celiprolol receives FDA orphan drug status for Ehlers-Danlos syndrome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...